NeoGenomics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Press Release
Read More
NeoGenomics Schedules its Second Quarter 2022 Earnings Release for August 9, 2022
Press Release
Read More
NeoGenomics Liquid Biopsy Subsidiary Inivata Announces New Data Demonstrating Clinical Potential of the RaDaR(TM) MRD Test in HR+ HER2- Breast Cancer
Press Release
Read More